SPRY — ARS Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapNeutral

Annual balance sheet for ARS Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	254	274	228	314	245
Net Total Accounts Receivable
Net Total Receivables	—	—	—	9.16	25.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	261	278	232	334	285
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	6.95	0.774	0.824	1.07	2.46
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	333	281	233	351	328
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	14.9	5.44	2.39	23.4	39.1
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	19.7	8.55	2.43	94.4	213
Redeemable Preferred Stock
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	314	273	231	257	114
Total Liabilities & Shareholders' Equity	333	281	233	351	328
Total Common Shares Outstanding